we investigated by immunohistochemistry the pepsinogen C (pepC) expression in uveal melanomas and analyzed the possible relationship to clinicopathological parameters and prognostic significance.
Methods
We studied 22 patients who had undergone enucleation of the eyeball or local tumor resection for uveal melanoma. The specimens were immunostained for pepC on formalin-fixed, paraffin-embedded sections. Sex, age, tumor location, histological type, local invasion, postoperative treatment and metastasis were evaluated.
Results
Eleven tumors (50%) were positive for pepsinogen C. The percentage of pepC-positive tumors was significantly higher in uveal melanomas with scleral invasion than in those without scleral invasion (p<0.01). PepC expression was significantly associated with a shortened overall survival (p<0.05).
Conclusions
Our results show that pepsinogen C may be expressed by uveal melanoma and suggest that this protein could be considered as a new, unfavorable prognostic factor in these tumors.
ScottoJ., FraumeniJ.F., LeeJ.A.. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects.J Natl Cancer Inst1976; 56: 489–91.
2.
LommatzchP., DietrichB.. Survival rate of patients with choroidal melanoma.Ophthalmologica1976; 173: 453–62.
3.
KrollS., CharD.H., QuiveyJ., CastroJ.. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.Ophthalmology1998; 105: 2035–45.
4.
RaivioY.. Uveal melanoma in Finland: an epidemiological, clinical and prognostic study.Acta Ophthalmol Suppl (Copenh)1977; 133: 1–64.
5.
AffeldtJ.C., MincklerD.S., AzenS.P., YehL.. Prognosis in uveal melanoma with extrascleral extension.Arch Ophthalmol1980; 98: 1975–9.
6.
PachJ.M., RobertsonD.M., TaneyB.S.. Prognosis factors in choroidal and ciliary body melanomas with extrascleral extension.Am J Ophthalmol1986; 101: 325–31.
7.
ZimmermanL.E., McLeanI.W., FosterW.D.. Statistical analysis of follow-up data concerning uveal melanomas, and the influence of enucleation.Ophthalmology1980; 87: 557–64.
8.
FoltmannB.. Gastric proteinases - structure, function, evolution and mechanism of action.Essays Biochem1981; 17: 52–84.
9.
TangJ., WongR.N.S.. Evolution in the structure and function of aspartic proteases.J Cell Biochem1987; 33: 53–63.
10.
TentiP., AguzziA., RivaC.. Ovarian mucinous tumors frequently express markers of gastric, intestinal, and pancreatobiliary epithelial cells.Cancer1992; 69: 2131–42.
11.
TentiP., RomagnoliS., SiliniE.. Cervical adenocarcinomas express markers common to gastric, intestinal, and pancreatobiliary epithelial cells.Pathol Res Pract1994; 190: 342–9.
12.
KonishiN., NakaokaS., MatsumotoK.. Expression of pepsinogen II with androgen and estrogen receptors in human prostate carcinoma.Pathol Int1999; 49: 203–7.
13.
MerinoA.M., VízquezJ., RodríguezJ.C.. Pepsinogen expression in tumors from extragastric origin.Int J Biol Markers2000; 15: 165–70.
14.
QuintelaI., VizosoF., SerraC.. Immunohistochemical study of the pepsinogen C expression in cutaneous malignant melanoma: association with clinico-pathologic parameters.Int J Biol Markers2001; 16: 240–4.
15.
VizosoF., SínchezL.M., Díez-ItzaI.. Pepsinogen C is a new progostic marker in primary breast cancer.J Clin Oncol1995; 13: 54–61.
16.
ScorilasA., DiamandisE.P., LevesqueM.A.. Immunoenzymatically determined pepsinogen C concentration in breast cytosols: an independent favorable prognostic factor in node-positive patients.Clin Cancer Res1999; 5: 1778–85.
17.
BalbínM., López-OtínC.. Hormonal regulation of the human pepsinogen C gene in breast cancer cells. Identification of a cis-acting element mediating its induction by androgens, glucocorticoids, and progesterone.J Biol Chem1996; 271: 15175–81.
18.
SínchezL.M., VizosoF., Díez-ItzaI., López-OtínC.. Identification of the major protein components in breast secretions from women with benign and malignant breast diseases.Cancer Res1992; 52: 95–100.
19.
KaplanE.L., MeierP.. Nonparametric estimation from incomplete observations.J Am Biochem1976; 72: 248–54.
20.
MantelN., MyersM.. Problems of convergence of maximum likelihood iterative procedures in multiparameter situations.J Am Stat Assoc1971; 66: 484–91.
21.
PackG.T., ScharnagelM.L.. The prognosis for malignant melanoma in the pregnant woman.Cancer1951; 4: 324–34.
22.
BeralV., RamcharanS., FarisR.. Malignant melanoma and oral contraceptive use among women in California.Br J Cancer1977; 36: 804–9.
23.
McKeageM.J., LorentzosA., GoreM.E.. Tamoxifen and chemotherapy for refractory metastatic malignant melanoma.N Engl J Med1993; 328: 140–1.
24.
MorvilloV., LuthyI.A., CapuroM.I.. Atypical androgen receptor in the human melanoma cell line IIB-MEL-J.Pigment Cell Res1995; 8: 135–41.
